Mission

To identify new trends and methodological challenges in oncology health economics and outcomes research with the intent of supporting education, awareness, and community engagement while working towards the development of recommendations to address them. 

Background

Oncology is one of the most rapidly evolving therapeutic areas with considerable clinical and economic burden. Health economics and outcomes research in oncology is complicated by (1) the diversity of the epidemiology and biology of various tumors, which limits the sample size and long-term follow-up in clinical trials, (2) the rapidly evolving treatment landscapes and variation in national management recommendations, and (3) the complexities of measuring costs and quality of life in patients and caregivers. Therefore, oncology health economics and outcomes research constitutes a unique segment, and our SIG aims to advance clinical and methodological knowledge for proper clinical and economic evaluation of oncology treatments and diagnostic tools.  

Goals

Engage the oncology community to raise awareness of key components in oncology HEOR and recommended practices.

Offer relevant and impactful educational presentations and activities on the latest oncology HEOR topics.

Create a space to support the discussion of methods of statistical analysis and economic evaluation in oncology, and approaches to support timely access of innovative oncology treatments and diagnostic tools.

Leadership



Chair-Elect

Shilpi Swami, MA

ConnectHEOR
London, LON, United Kingdom

Past Chair

Brittany Carson, PhD, MHEcon, BSc

Senior Medical Director, ApotheCom
New York, NY, United States

Chair

Min-Hua Jen, PhD

Sr. Director, Eli Lilly
Uxbridge, LON, United Kingdom

Working Groups


Member Engagement



Co-Chairs

Jagadeswara Rao Earla, MBA, PharmD, PhD

Associate Director, Outcomes Research, Merck & Co. Inc
Rahway, NJ, United States

Haidong Feng

Associate Principal Scientist, Merck
Boston, MA, United States

Marco Gross-Langenhoff

Global HEOR Lead Oncology, Astellas Pharma
Munich, BY, Germany

Sabina Nduaguba, MSc

Assistant Professor, West Virginia University
Morgantown, WV, United States

Lixia Yao, PhD

Associate Professor, Temple University
Chalfont, PA, United States

Questions or ideas? Please send an email to Oncologysig@ISPOR.org

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×